Cancer waiting times: latest updates
Over the past few years, there has been extreme pressure [...]
WECAN Academy 2024
Mid July, one of the Action Kidney Cancer team, Steve [...]
FDA grant fast track status to CAR T cell therapy for kidney cancer
The Food and Drug Administration (FDA) in America has granted [...]
Perioperative nivolumab in intermediate/high risk kidney cancer patients
The standard of care for patients with intermediate/high risk kidney [...]
